Fundraising Fox에이투젠
1 known investors
Find your way into 에이투젠
Sign up to see every warm intro you have to 에이투젠
- Paths you didn't know you had: your email and LinkedIn already hold routes to the 에이투젠 team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
ATOGEN is a South Korean biotech company developing microbiome-based therapeutics and healthcare materials by discovering functional strains and analyzing the human gut microbiome. It applies strain cultivation processes and multi-omics analysis (genomics, transcriptomics, metabolomics) to develop drugs targeting various diseases.
Investors · 1
Frequently asked questions
- What does 에이투젠 do?
- ATOGEN is a South Korean biotech company developing microbiome-based therapeutics and healthcare materials by discovering functional strains and analyzing the human gut microbiome. It applies strain cultivation processes and multi-omics analysis (genomics, transcriptomics, metabolomics) to develop drugs targeting various diseases.
- Who are 에이투젠's investors?
- 에이투젠's investors include SBI Investment Korea Co. Ltd..